KALA BIO, INC. Financing Cash Flow
KALA BIO, INC. (KALA) reported Financing Cash Flow of $4.10 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-19
- KALA BIO, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $0.00.
- KALA BIO, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $4.10M.
- KALA BIO, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$8.98M, a 235.16% decline year-over-year.
- KALA BIO, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $30.00K.
- KALA BIO, INC. net cash provided by (used in) financing activities for fiscal 2025 was -$11.62M, a 138.89% decline from fiscal 2024.
- KALA BIO, INC. net cash provided by (used in) financing activities for fiscal 2024 was $29.88M, a 251.23% increase from fiscal 2023.
- KALA BIO, INC. net cash provided by (used in) financing activities for fiscal 2023 was $8.51M.
- KALA BIO, INC. net cash provided by (used in) financing activities for fiscal 2022 was -$7.94M, a 118.66% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-19 | $4.10M 10-Q · filed 2026-08-19 | -$4.88M derived: sum of 3 quarters · filed 2026-08-19 | -$4.85M derived: sum of 4 quarters · filed 2026-08-19 |
| 2026-03-31 | $4.10M 10-Q · filed 2026-05-15 | -$4.88M derived: sum of 2 quarters · filed 2026-05-15 | -$4.85M derived: sum of 3 quarters · filed 2026-05-15 | -$7.38M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-12-31 | -$8.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$8.95M derived: sum of 2 quarters · filed 2026-04-15 | -$11.48M derived: sum of 3 quarters · filed 2026-08-19 | -$11.62M 10-K · filed 2026-04-15 |
| 2025-09-30 | $30.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | -$2.50M derived: sum of 2 quarters · filed 2026-08-19 | -$2.63M 10-Q · filed 2025-11-19 | $4.01M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-06-30 | -$2.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-19 | -$2.67M 10-Q · filed 2026-08-19 | $3.98M derived: sum of 3 quarters · filed 2026-08-19 | $3.80M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-03-31 | -$135.00K 10-Q · filed 2026-05-15 | $6.51M derived: sum of 2 quarters · filed 2026-05-15 | $6.33M derived: sum of 3 quarters · filed 2026-05-15 | $21.30M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $6.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $6.47M derived: sum of 2 quarters · filed 2026-04-15 | $21.44M derived: sum of 3 quarters · filed 2026-04-15 | $29.88M 10-K · filed 2026-04-15 |
| 2024-09-30 | -$180.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $14.79M derived: sum of 2 quarters · filed 2025-11-19 | $23.23M 10-Q · filed 2025-11-19 | $25.77M derived: sum of 4 quarters · filed 2025-11-19 |
| 2024-06-30 | $14.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $23.41M 10-Q · filed 2025-08-08 | $25.95M derived: sum of 3 quarters · filed 2025-08-08 | $25.98M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $8.44M 10-Q · filed 2025-05-14 | $10.97M derived: sum of 2 quarters · filed 2025-05-14 | $11.02M derived: sum of 3 quarters · filed 2025-05-14 | $14.09M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $2.54M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $2.58M derived: sum of 2 quarters · filed 2025-03-31 | $5.65M derived: sum of 3 quarters · filed 2025-03-31 | $8.51M 10-K · filed 2025-03-31 |
| 2023-09-30 | $40.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $3.11M derived: sum of 2 quarters · filed 2024-11-12 | $5.97M 10-Q · filed 2024-11-12 | $37.76M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $3.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $5.93M 10-Q · filed 2024-08-06 | $37.72M derived: sum of 3 quarters · filed 2024-08-06 | -$2.15M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $2.86M 10-Q · filed 2024-05-14 | $34.64M derived: sum of 2 quarters · filed 2024-05-14 | -$5.23M derived: sum of 3 quarters · filed 2024-05-14 | -$5.24M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $31.79M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$8.09M derived: sum of 2 quarters · filed 2024-03-29 | -$8.10M derived: sum of 3 quarters · filed 2024-03-29 | -$7.94M 10-K · filed 2024-03-29 |
| 2022-09-30 | -$39.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$39.88M derived: sum of 2 quarters · filed 2023-11-13 | -$39.73M 10-Q · filed 2023-11-13 | -$39.57M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $144.00K 10-Q · filed 2023-08-04 | $304.00K derived: sum of 3 quarters · filed 2023-08-04 | $1.53M derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $154.00K 10-Q · filed 2023-05-09 | $314.00K derived: sum of 2 quarters · filed 2023-05-09 | $1.54M derived: sum of 3 quarters · filed 2023-05-09 | $7.39M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $160.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | $1.39M derived: sum of 2 quarters · filed 2023-03-03 | $7.24M derived: sum of 3 quarters · filed 2023-03-03 | $42.55M 10-K · filed 2023-03-03 |
| 2021-09-30 | $1.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $7.08M derived: sum of 2 quarters · filed 2022-11-08 | $42.39M 10-Q · filed 2022-11-08 | $63.12M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $5.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $41.16M 10-Q · filed 2022-08-11 | $61.89M derived: sum of 3 quarters · filed 2022-08-11 | $62.63M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $35.31M 10-Q · filed 2022-05-16 | $56.04M derived: sum of 2 quarters · filed 2022-05-16 | $56.78M derived: sum of 3 quarters · filed 2022-05-16 | $64.76M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $20.72M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $21.47M derived: sum of 2 quarters · filed 2022-03-29 | $29.45M derived: sum of 3 quarters · filed 2022-03-29 | $160.63M 10-K · filed 2022-03-29 |
| 2020-09-30 | $746.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $8.72M derived: sum of 2 quarters · filed 2021-11-15 | $139.91M 10-Q · filed 2021-11-15 | $146.20M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $7.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $139.16M 10-Q · filed 2021-08-05 | $145.46M derived: sum of 3 quarters · filed 2021-08-05 | $148.12M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $131.18M 10-Q · filed 2021-05-05 | $137.48M derived: sum of 2 quarters · filed 2021-05-05 | $140.14M derived: sum of 3 quarters · filed 2021-05-05 | $140.13M derived: sum of 4 quarters · filed 2021-05-05 |
| 2019-12-31 | $6.29M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $8.96M derived: sum of 2 quarters · filed 2021-02-25 | $8.95M derived: sum of 3 quarters · filed 2021-02-25 | $8.98M 10-K · filed 2021-02-25 |
| 2019-09-30 | $2.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $2.66M derived: sum of 2 quarters · filed 2020-11-05 | $2.69M 10-Q · filed 2020-11-05 | $125.60M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | -$10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $19.00K 10-Q · filed 2020-08-06 | $122.93M derived: sum of 3 quarters · filed 2020-08-06 | $122.98M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $29.00K 10-Q · filed 2020-05-07 | $122.94M derived: sum of 2 quarters · filed 2020-05-07 | $122.99M derived: sum of 3 quarters · filed 2020-05-07 | $123.04M derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | $122.92M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-12 | $122.96M derived: sum of 2 quarters · filed 2020-02-12 | $123.02M derived: sum of 3 quarters · filed 2020-02-12 | $124.10M 10-K · filed 2020-02-12 |
| 2018-09-30 | $45.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $100.00K derived: sum of 2 quarters · filed 2019-11-07 | $1.19M 10-Q · filed 2019-11-07 | $552.00K derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $55.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $1.14M 10-Q · filed 2019-08-06 | $507.00K derived: sum of 3 quarters · filed 2019-08-06 | $105.62M derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-03-31 | $1.09M 10-Q · filed 2019-05-09 | $452.00K derived: sum of 2 quarters · filed 2019-05-09 | $105.57M derived: sum of 3 quarters · filed 2019-05-09 | $104.80M derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | -$637.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $104.48M derived: sum of 2 quarters · filed 2019-03-12 | $103.72M derived: sum of 3 quarters · filed 2019-03-12 | $103.70M 10-K · filed 2019-03-12 |
| 2017-09-30 | $105.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $104.35M derived: sum of 2 quarters · filed 2018-11-08 | $104.33M 10-Q · filed 2018-11-08 | $105.31M derived: sum of 4 quarters · filed 2018-11-08 |
| 2017-06-30 | -$765.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$784.00K 10-Q · filed 2018-08-09 | $193.00K derived: sum of 3 quarters · filed 2018-08-09 | -$808.00K derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-03-31 | -$19.00K 10-Q · filed 2018-05-10 | $958.00K derived: sum of 2 quarters · filed 2018-05-10 | -$43.00K derived: sum of 3 quarters · filed 2018-05-10 | |
| 2016-12-31 | $977.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -$24.00K derived: sum of 2 quarters · filed 2018-04-02 | $67.21M 10-K · filed 2018-04-02 | |
| 2016-09-30 | -$1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $66.24M 10-Q · filed 2017-11-07 | ||
| 2016-06-30 | $67.24M 10-Q · filed 2017-08-31 | |||
| 2015-12-31 | $10.48M 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |